comparemela.com
  1. Home
  2. Live Updates
  3. Cytokine Based Drug Development Summit - Breaking News

Latest Breaking News On - Cytokine based drug development summit - Page 1 : comparemela.com

Medicenna Therapeutics Corp (MDNA) CEO Fahar Merchant on Q1 2023 Results - Earnings Call Transcript

Medicenna Therapeutics Corp. (NASDAQ:NASDAQ:MDNA) Q1 2023 Earnings Conference Call August 15, 2022, 08:30 AM ET Company Participants Dan Ferry - IR, LifeSci Advisors Fahar Merchant -.

United statesLiz williamsMatt bieglerDavid martinCatherine novackMedicenna therapeutics corpCompany participantsJones researchDrug development summitMedicenna therapeuticsConference call augustFirst quarter fiscalDan ferryAnnual information formFahar merchantChief executive officer

Medicenna Therapeutics (MDNA) Announces New Clinical Data Providing Preliminary Evidence of MDNA11 s Single Agent Anti-Cancer Activity in the Phase 1/2 ABILITY Study

Medicenna Therapeutics (MDNA) Announces New Clinical Data Providing Preliminary Evidence of MDNA11 s Single Agent Anti-Cancer Activity in the Phase 1/2 ABILITY Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Medicenna therapeutics corpCytokine based drug development summitSafety review committeeWall streetCytokine based drug developmentFahar merchantInnate immune cellsAchieve clinical benefit
© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.